PIMS Issues Medical Update on Imran Khan’s Eye Treatment

Second Dose of Anti-VEGF Injection Administered Successfully; Patient Remains Stable

ISLAMABAD: The Pakistan Institute of Medical Sciences (PIMS) has issued a medical update pertaining to former prime minister and Pakistan Tehreek-e-Insaf founder Imran Ahmad Khan Niazi, aged 74, confirming that he was brought to the hospital on February 24, 2026, for a scheduled follow-up of his eye condition.

Executive Director Pakistan Institute of Medical Sciences (PIMS) Professor Dr Rana Imran Sikander, in a statement, said that during the visit, he was administered the second dose of an Anti-VEGF intravitreal injection as part of his ongoing ophthalmic treatment.

The statement reads, “Prior to the procedure, a multidisciplinary medical board conducted a comprehensive evaluation. The board included a Consultant Cardiologist who performed echocardiography and ECG examinations; both results were reported as normal. A Consultant Physician also examined Imran Khan and found him medically stable for the procedure, it added.

The statement further stated that after obtaining informed consent, and under strict monitoring protocols and precautionary measures in the operation theatre, the injection was administered under microscopic guidance, adding that the procedure was performed by a Consultant Ophthalmologist and a Consultant Vitreo-Retinal Surgeon (PIMS and Al-Shifa Eye Hospital) as a day-care surgery.

“Throughout his stay — before, during, and after the procedure — Imran Khan remained stable with normal vital signs. Following the successful completion of the procedure, he was discharged with necessary care instructions, follow-up advice, and relevant medical documentation,” the statement concluded.

It is pertinent to mention here that earlier Imran Khan was taken to the PIMS hospital for medical procedure on the night of January 24. During which, PIMS ED said that the procedure was completed smoothly in approximately 20 minutes, adding that during the treatment, the patient remained vitally stable and was discharged with routine post-procedure care instructions and follow-up advice and documents.